Cargando…

Comparative efficacy of patiromer and sodium polystyrene sulfonate on potassium levels in chronic haemodialysis patients: a randomized crossover trial

BACKGROUND: Hyperkalaemia is frequent in haemodialysis (HD) patients and associated with increased cardiovascular mortality. Despite routine clinical use, evidence regarding the efficacy of potassium (K(+)) binders in HD is scant. We wished to compare the efficacy of patiromer (PAT) and sodium polys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaques, David A, Stucker, Fabien, Ernandez, Thomas, Alves, Cyrielle, Martin, Pierre-Yves, De Seigneux, Sophie, Saudan, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494516/ https://www.ncbi.nlm.nih.gov/pubmed/36158152 http://dx.doi.org/10.1093/ckj/sfac129

Ejemplares similares

Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure
por: Patel, Shardool, et al.
Publicado: (2023)

Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review
por: Beccari, Mario V, et al.
Publicado: (2017)

Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review [Erratum]
Publicado: (2019)

Outcomes of incident patients treated with incremental haemodialysis as compared with standard haemodialysis and peritoneal dialysis
por: Jaques, David A, et al.
Publicado: (2022)

To Bind or to Let Loose: Effectiveness of Sodium Polystyrene Sulfonate in Decreasing Serum Potassium
por: Sandal, Shaifali, et al.
Publicado: (2012)

Sodium polystyrene sulfonate (Kayexalate) aspiration
por: Gonzalez-Cuyar, Luis F, et al.
Publicado: (2008)

Sodium-Polystyrene Sulfonate-Induced Colitis
por: dos Santos, Francisco Souza, et al.
Publicado: (2021)

Impact of superimposed nephrological care to guidelines-directed management by primary care physicians of patients with stable chronic kidney disease: a randomized controlled trial
por: Saudan, Patrick, et al.
Publicado: (2020)

Palatability and physical properties of potassium-binding resin RDX7675: comparison with sodium polystyrene sulfonate
por: Zann, Vanessa, et al.
Publicado: (2017)

Hypernatremia in a patient treated with sodium polystyrene sulfonate
por: Nepal, Manish, et al.
Publicado: (2010)

Interaction behavior of polyion-counterion for sodium polystyrene sulfonate
por: Bhattarai, Ajaya
Publicado: (2019)

Amitriptyline, clomipramine, and doxepin adsorption onto sodium polystyrene sulfonate
por: Jamshidzadeh, Akram, et al.
Publicado: (2014)

Lower Gastrointestinal Bleeding Associated With Sodium Polystyrene Sulfonate Use
por: Dantas, Eduardo, et al.
Publicado: (2021)

Letter to the editor regarding ‘‘Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-analysis: Patiromer and Sodium Zirconium Cyclosilicate in Hyperkalemia’
por: Zarzuela, Donna, et al.
Publicado: (2021)

Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics
por: Gagnebin, Yoric, et al.
Publicado: (2020)

Sodium polystyrene sulfonate induced intestinal necrosis; a case report
por: Almulhim, Abdulaziz Saleh, et al.
Publicado: (2018)

Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis
por: Nakamura, Teruko, et al.
Publicado: (2018)

Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
por: Rosano, Giuseppe M C, et al.
Publicado: (2019)

Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: a prospective observational study
por: Stucker, Fabien, et al.
Publicado: (2017)

Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
por: Singhania, Namrata, et al.
Publicado: (2020)

Sodium Polystyrene Sulfonate-Induced Gastric Pneumatosis: A Rare Side Effect
por: Dasu, Neethi, et al.
Publicado: (2021)

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
por: Bushinsky, David A, et al.
Publicado: (2015)

Gut Microbiota and Host Cometabolism Are Altered by Patiromer-Induced Changes in Serum and Stool Potassium
por: Gao, Bei, et al.
Publicado: (2020)

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
por: Esteban‐Fernández, Alberto, et al.
Publicado: (2022)

Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats
por: Ayoub, Isabelle, et al.
Publicado: (2015)

The Successful Treatment of Sodium Polystyrene Sulfonate-induced Enteritis Diagnosed by Small Bowel Endoscopy
por: Okayama, Kohei, et al.
Publicado: (2018)

Sodium Polystyrene Sulfonate and Cytomegalovirus-Associated Hemorrhagic Duodenitis: More than Meets the Eye
por: Gürtler, Nicolas, et al.
Publicado: (2018)

Patiromer sorbitex calcium for hyperkalaemia
Publicado: (2019)

Dietary sodium intake does not alter renal potassium handling and blood pressure in healthy young males
por: Pechère-Bertschi, Antoinette, et al.
Publicado: (2021)

Pseudohypoaldosteronism Type 1 (arPHA1) Treated With Sodium Polystyrene Sulfonate Pretreated Milk
por: Khalil, Syed Tariq, et al.
Publicado: (2015)

A Fishy Appearance: A Rare Image of Sodium Polystyrene Sulfonate-Induced Ischemic Colitis
por: Chen, Eugenia Y., et al.
Publicado: (2020)

Modulating Role of Co-Solutes in Complexation between Bovine Serum Albumin and Sodium Polystyrene Sulfonate
por: Simončič, Matjaž, et al.
Publicado: (2022)

Binding interactions with sevelamer and polystyrene sulfonate in vitro
por: van Berlo‐van de Laar, Inge R.F., et al.
Publicado: (2021)

Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2021)

Case report: Patiromer-induced hypercalcemia
por: Wiederkehr, Michael R., et al.
Publicado: (2019)

One Oral Dose of Sodium Polystyrene Sulfonate Associated with Ischemic Colitis and Crystal Deposition in Colonic Mucosa
por: Edhi, Ahmed I., et al.
Publicado: (2018)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
por: Nakayama, Takashin, et al.
Publicado: (2023)

Adverse Gastrointestinal Events With Sodium Polystyrene Sulfonate Use in Patients on Maintenance Hemodialysis: An International Cohort Study
por: Farfan Ruiz, Ana Cecilia, et al.
Publicado: (2023)

Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease
por: Pinnell, Derek, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m83jahohrd7rjs9hecd8tds446